Skip to main content
. 2019 Mar 6;11:53–60. doi: 10.2147/RRU.S187950

Table 2.

Final surgical pathology of all patients undergoing RP broken down by biopsy GG

All patients
N=2,310 (n, %)
GG 1
N=906 (n, %)
GG 2
N=1,048 (n, %)
GG 3
N=231 (n, %)
GG 4
N=69 (n, %)
GG 5
N=56 (n, %)

RP GG
1 514 (22.2) 434 (48) 78 (7) 1 (0.5) 0 (0) 0 (0)
2 1,287 (56) 430 (47) 771 (74) 73 (32) 10 (14) 3 (0.5)
3 349 (15) 29 (3) 170 (16) 116 (50) 21 (30) 13 (23)
4 54 (2.2) 9 (1) 12 (1) 17 (7) 15 (22) 1 (1.8)
5 106 (4.6) 4 (1) 17 (2) 23 (10.5) 23 (34) 39 (74.7)

pT
pT2 1,766 (76.5) 827 (91.3) 763 (72.8) 130 (56.3) 33 (47.8) 13 (23.2)
pT3a 370 (16.0) 68 (7.5) 200 (19.1) 63 (27.3) 20 (29.0) 19 (33.9)
pT3b 174 (7.5) 11 (1.2) 85 (8.1) 38 (16.5) 16 (23.2) 24 (42.9)

pN
pN0 1,838 (79.6) 619 (68.3) 896 (85.5) 209 (90.5) 67 (97.1) 47 (83.9)
pN1 34 (1.5) 2 (0.2) 14 (1.3) 10 (4.3) 1 (1.5) 7 (12.5)
pNx 438 (19.0) 285 (31.5) 138 (13.2) 12 (5.2) 1 (1.5) 2 (3.6)

Surgical margins
pT2
 Negative 1,324 (75.0) 636 (76.9) 559 (73.3) 94 (72.3) 26 (78.8) 9 (69.2)
 Positive 442 (25.0) 191 (23.1) 204 (26.7) 36 (27.7) 7 (21.2) 4 (30.8)
pT3
 Negative 271 (49.8) 33 (41.8) 153 (53.7) 47 (46.5) 18 (50.0) 20 (46.5)
 Positive 273 (50.2) 46 (58.2) 132 (46.2) 54 (53.5) 18 (50.0) 23 (53.5)

EPE
Absent 1,745 (75.5) 719 (79.4) 778 (74.2) 158 (68.4) 51 (73.9) 39 (69.6)
Focal 263 (11.4) 97 (10.7) 125 (11.9) 30 (13.0) 7 (10.1) 4 (7.1)
Established 302 (13.1) 90 (9.9) 145 (13.8) 43 (18.6) 11 (15.9) 13 (23.2)

SVI
Absent 2,137 (92.5) 895 (98.8) 963 (91.9) 193 (83.6) 53 (76.8) 33 (58.9)
Present 173 (7.5) 11 (1.2) 85 (8.1) 38 (16.5) 16 (23.2) 23 (41.1)

Abbreviations: EPE, extraprostatic extension; GG, Grade Group; RP, radical prostatectomy; SVI, seminal vesicle invasion.